Importantly, higher CD97 expression levels were associated with poorer overall survival of AML patients, while CD97-knockdown negatively modulated cellular adhesion, migration, and FMS-like tyrosine kinase 3 (FLT3) gene expression in some AML cell lines [110,113]. This evidence concerns the gene ADGRE2 and acute myeloid leukemia.